Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Vitiligo: recent insights and new therapeutic approaches.

Lotti TM, Berti SF, Hercogova J, Huggins RH, Lee BW, Janniger CK, Schwartz RA.

G Ital Dermatol Venereol. 2012 Dec;147(6):637-47. Review.

PMID:
23149710
2.

Vitiligo.

Huggins RH, Schwartz RA, Janniger C.

Acta Dermatovenerol Alp Pannonica Adriat. 2005 Dec;14(4):137-42, 144-5. Review.

3.

Childhood vitiligo.

Huggins RH, Schwartz RA, Janniger CK.

Cutis. 2007 Apr;79(4):277-80. Review.

PMID:
17500374
4.

Pediatric vitiligo.

Silverberg NB.

Pediatr Clin North Am. 2014 Apr;61(2):347-66. doi: 10.1016/j.pcl.2013.11.008. Epub 2014 Jan 28. Review.

PMID:
24636650
5.

Recent advances in childhood vitiligo.

Silverberg NB.

Clin Dermatol. 2014 Jul-Aug;32(4):524-30. doi: 10.1016/j.clindermatol.2014.02.006. Epub 2014 Feb 28. Review.

PMID:
25017463
6.

The genetics of generalized vitiligo and associated autoimmune diseases.

Spritz RA.

Pigment Cell Res. 2007 Aug;20(4):271-8. Review.

PMID:
17630960
7.

Recent investigations on vitiligo vulgaris.

Nordlund JJ, Majumder PP.

Dermatol Clin. 1997 Jan;15(1):69-78. Review.

PMID:
9001862
8.

Childhood vitiligo.

Silverberg NB, Travis L.

Cutis. 2006 Jun;77(6):370-5. Review.

PMID:
16838770
9.

[Vitiligo in childhood].

Prćić S, Duran V, Poljacki M.

Med Pregl. 2002 Nov-Dec;55(11-12):475-80. Croatian.

PMID:
12712889
10.

The genetics of generalized vitiligo and associated autoimmune diseases.

Spritz RA.

J Dermatol Sci. 2006 Jan;41(1):3-10. Epub 2005 Nov 9. Review.

PMID:
16289692
11.

Vitiligo as a systemic disease.

Lotti T, D'Erme AM.

Clin Dermatol. 2014 May-Jun;32(3):430-4. doi: 10.1016/j.clindermatol.2013.11.011. Epub 2013 Nov 22. Review.

PMID:
24767192
12.

The genetics of generalized vitiligo.

Spritz RA.

Curr Dir Autoimmun. 2008;10:244-57. doi: 10.1159/000131501. Review.

PMID:
18460890
13.

CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.

Blomhoff A, Kemp EH, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE, Lie BA, Undlien DE.

Pigment Cell Res. 2005 Feb;18(1):55-8.

PMID:
15649153
14.

Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo.

Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, Spritz RA.

Pigment Cell Res. 2005 Aug;18(4):300-5.

PMID:
16029422
15.

Vitiligo: where do we stand?

Ortonne JP, Bose SK.

Pigment Cell Res. 1993 Mar;6(2):61-72. Review.

PMID:
8321867
16.

Vitiligo: pathogenetic hypotheses and targets for current therapies.

Guerra L, Dellambra E, Brescia S, Raskovic D.

Curr Drug Metab. 2010 Jun 1;11(5):451-67. Review.

PMID:
20540698
17.

Autoimmunity as an aetiological factor in vitiligo.

Rezaei N, Gavalas NG, Weetman AP, Kemp EH.

J Eur Acad Dermatol Venereol. 2007 Aug;21(7):865-76. Review.

PMID:
17658994
18.

Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.

Shajil EM, Chatterjee S, Agrawal D, Bagchi T, Begum R.

Indian J Exp Biol. 2006 Jul;44(7):526-39. Review.

PMID:
16872041
19.

[Vitiligo as an aesthetic problem. Noninvasive therapeutic methods in vitiligo].

Popko M, Kacalak-Rzepka A, Bielecka-Grzela S, Wesołowska J, Klimowicz A, Maleszka R.

Ann Acad Med Stetin. 2011;57(3):23-7. Review. Polish.

PMID:
23383544
20.

Physiopathology and genetics of vitiligo.

Passeron T, Ortonne JP.

J Autoimmun. 2005;25 Suppl:63-8. Epub 2005 Nov 18. Review.

PMID:
16298511

Supplemental Content

Support Center